It will also be essential to understand to what extent (potency and durability) each virus (measles, mumps, and rubella) contribute to the MMR-enabled antitumor activity and if it can effectively target and eradicate minimal residual disease and distant metastases in experimental cancer models, then clinical studies. This evidence concerns the gene MRC1 and rubella.